tm logo

Monitor this mark

View On USPTO

MIZKO
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 21 Nov 2024

Last Applicant/ Owned by

TEVA PHARMACEUTICALS USA, Inc.

400 Interpace Parkway

Parsippany

NJ

07054

Serial Number

97437817 filed on 01st Jun 2022

Registration Number

N/A

Correspondent Address

Laurence Rickles

Laurence Rickles TEVA PHARMACEUTICALS USA, INC.

BUILDING A

PARSIPPANY, NJ 07054

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MIZKO

Pharmaceutical preparations for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97437817

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
21st Nov 2024SOU EXTENSION 3 FILED
21st Nov 2024SOU EXTENSION 3 GRANTED
21st Nov 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21st Nov 2024SOU TEAS EXTENSION RECEIVED
13th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
31st May 2024SOU EXTENSION 2 FILED
31st May 2024SOU EXTENSION 2 GRANTED
31st May 2024SOU TEAS EXTENSION RECEIVED
29th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27th Nov 2023SOU EXTENSION 1 GRANTED